Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Total Non-Current Liabilities (2012 - 2026)

Zoetis' (ZTS) quarterly Total Non-Current Liabilities came in at $11.6 billion in Q2 2026, up 26.15% year-over-year from $9.2 billion in Q2 2025, and little changed quarter-over-quarter from $11.6 billion in Q1 2026.

Analysis

Zoetis (ZTS) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Total Non-Current Liabilities for 15 consecutive years, with $11.6 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 26.15% year-over-year to $11.6 billion in Q2 2026; TTM through Jun 2026 was $11.6 billion, a 26.15% increase from a year earlier, with the FY2025 full-year figure at $11.8 billion, up 28.32% from the prior year.
  • Total Non-Current Liabilities was $11.6 billion for Q2 2026 at Zoetis, roughly flat from $11.6 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $11.8 billion in Q4 2025 and troughed at $8.8 billion in Q3 2023.
  • A 5-year average of $9.5 billion and a median of $9.0 billion in 2023 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities dropped 12.08% in 2023 and rose 28.32% in 2025, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $10.3 billion in 2022, then decreased by 12.08% to $9.0 billion in 2023, then advanced by 1.89% to $9.2 billion in 2024, then rose by 28.32% to $11.8 billion in 2025, then retreated by 1.34% to $11.6 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $11.6 billion (Q2 2026), $11.6 billion (Q1 2026), and $11.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn 542.10 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 11.64 Bn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn 6.42 Bn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 1.02 Bn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn 10.82 Mn
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - 1.31 Mn
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.64 Bn
Mar 31, 2026 11.64 Bn
Dec 31, 2025 11.80 Bn
Sep 30, 2025 9.49 Bn
Jun 30, 2025 9.23 Bn
Mar 31, 2025 9.17 Bn
Dec 31, 2024 9.20 Bn
Sep 30, 2024 8.85 Bn
Jun 30, 2024 8.94 Bn
Mar 31, 2024 9.02 Bn
Dec 31, 2023 9.02 Bn
Sep 30, 2023 8.77 Bn
Jun 30, 2023 8.85 Bn
Mar 31, 2023 9.00 Bn
Dec 31, 2022 10.26 Bn
Sep 30, 2022 8.77 Bn
Jun 30, 2022 8.94 Bn
Mar 31, 2022 8.95 Bn
Dec 31, 2021 9.10 Bn
Sep 30, 2021 8.77 Bn